Raven Biotechnologies Company
.jpg)
Raven biotechnologies is focused on the development of monoclonal antibody therapeutics for the treatment of cancer.
Last Funding Type:
Series D
Headquarters:
South San Francisco, California, United States
Industry:
Women Cancer Treatment
Funding Status:
M&A
Total Funding:
$88 300 000